Renal response to candoxatrilat in patients with heart failure

This publication has 45 references indexed in Scilit:

• Candoxatril, an orally active neutral endopeptidase inhibitor, raises plasma atrial natriuretic factor and is natriuretic in essential hypertension
  Journal Of Hypertension, 1992
• Dietary sodium and inhibition of neutral endopeptidase 24.11 in essential hypertension.
  Hypertension, 1991
• Antihypertensive and Renal Activity of SQ 28,603, an Inhibitor of Neutral Endopeptidase
  Journal of Cardiovascular Pharmacology, 1991
• Augmentation of the natriuretic activity of exogenous and endogenous atriopeptin in rats by inhibition of guanosine 3',5'-cyclic monophosphate degradation.
  Journal of Clinical Investigation, 1990
• Effect of sinorphan on plasma atrial natriuretic factor in congestive heart failure
  The Lancet, 1990
• EFFECTS OF UK 69 578: A NOVEL ATRIOPEPTIDASE INHIBITOR
  Published by Elsevier ,1989
• The Biochemical Pharmacology of Atrial Peptides
  Annual Review of Pharmacology and Toxicology, 1989
• The hydrolysis of α-human atrial natriuretic peptide by pig kidney microvillar membranes is initiated by endopeptidase-24.11
  Biochemical Journal, 1987
• Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.
  Journal of Clinical Investigation, 1986
• Plasma alpha natriuretic peptide in cardiac impairment.
  BMJ, 1986